Triciribine
Triciribine is a synthetic tricyclic nucleoside that has been studied for its potential use as an anti-cancer agent. It is known for its ability to inhibit Akt (also known as Protein Kinase B), which plays a crucial role in various cellular processes including glucose metabolism, apoptosis, cell proliferation, transcription, and cell migration.
Chemical Structure and Properties[edit | edit source]
Triciribine, also known as API-2, has a chemical structure that includes a tricyclic ring system. Its molecular formula is C13H14N4O3, and it has a molecular weight of 274.28 g/mol. The compound is characterized by its ability to interfere with the phosphorylation of Akt, thereby inhibiting its activity.
Mechanism of Action[edit | edit source]
Triciribine functions primarily by inhibiting the phosphorylation of Akt, a serine/threonine-specific protein kinase. Akt is a key component of the PI3K/AKT/mTOR pathway, which is involved in cell survival and growth. By inhibiting Akt, Triciribine can induce apoptosis in cancer cells and inhibit tumor growth. This makes it a promising candidate for cancer therapy, particularly in cancers where the Akt pathway is dysregulated.
Clinical Applications[edit | edit source]
Triciribine has been investigated in various clinical trials for its efficacy in treating different types of cancer, including breast cancer, prostate cancer, and melanoma. Although it has shown potential in preclinical studies, its clinical development has faced challenges, including issues related to its bioavailability and toxicity.
Research and Development[edit | edit source]
Ongoing research is focused on improving the delivery and efficacy of Triciribine. Strategies include the development of Triciribine derivatives and combination therapies with other anti-cancer agents. Researchers are also exploring its potential use in combination with chemotherapy and radiotherapy to enhance its anti-tumor effects.
Related Pages[edit | edit source]
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD
